Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside

被引:44
作者
Bian, Yaqi
Zhao, Chen
Lee, Simon Ming-Yuen [1 ]
机构
[1] Univ Macau, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
来源
FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷
关键词
saffron; saffron constituents; anti-depressant effect; anxiolytic effect; neuroprotective effects; traditional Chinese medicine; CROCUS-SATIVUS-L; TO-MODERATE DEPRESSION; MILD COGNITIVE IMPAIRMENT; DOUBLE-BLIND; AQUEOUS EXTRACT; ACTIVE CONSTITUENTS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; SAFETY EVALUATION;
D O I
10.3389/fphar.2020.579052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The increasing morbidity rates of brain disorders and conditions such as anxiety, depression, Alzheimer's disease, and Parkinson's disease have become a severe problem in recent years. Although researchers have spent considerable time studying these diseases and reported many positive outcomes, there still are limited drugs available for their treatment. As a common traditional Chinese medicine (TCM), saffron was employed to treat depression and some other inflammatory diseases in ancient China due to its antioxidant, anti-inflammatory, and antidepressant properties. In modern times, saffron and its constituents have been utilized, alone and in TCM formulas, to treat neuropsychiatric and neurodegenerative diseases. In this review, we mainly focus on recent clinical and preclinical trials of brain disorders in which saffron was applied, and summarize the neuroprotective properties of saffron and its constituents from chemical, pharmacokinetic, and pharmacological perspectives. We discuss the properties of saffron and its constituents, as well as their applications for treating brain disorders; we hope that this review will serve as a comprehensive reference for studies aimed at developing therapeutic drugs based on saffron.
引用
收藏
页数:13
相关论文
共 142 条
  • [1] Neuroprotection by crocetin in a hemi-parkinsonian rat model
    Ahmad, AS
    Ansari, MA
    Ahmad, M
    Saleem, S
    Yousuf, S
    Hoda, MN
    Islam, F
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 81 (04) : 805 - 813
  • [2] Crocetin inhibits beta-amyloid fibrillization and stabilizes beta-amyloid oligomers
    Ahn, Joon Ho
    Hu, Yang
    Hernandez, Michael
    Kim, Jin Ryoun
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 414 (01) : 79 - 83
  • [3] Crocus sativus L. in the treatment of mild to moderate depression:: A double-blind, randomized and placebo-controlled trial
    Akhondzadeh, S
    Tahmacebi-Pour, N
    Noorbala, AA
    Amini, H
    Fallah-Pour, H
    Jamshidi, AH
    Khani, M
    [J]. PHYTOTHERAPY RESEARCH, 2005, 19 (02) : 148 - 151
  • [4] Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial
    Akhondzadeh, S.
    Shafiee-Sabet, M.
    Harirchian, M. H.
    Togha, M.
    Cheraghmakani, H.
    Razeghi, S.
    Hejazi, S. Sh
    Yousefi, M. H.
    Alimardani, R.
    Jamshidi, A.
    Zare, F.
    Moradi, A.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (05) : 581 - 588
  • [5] Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]
    Akhondzadeh S.
    Fallah-Pour H.
    Afkham K.
    Jamshidi A.-H.
    Khalighi-Cigaroudi F.
    [J]. BMC Complementary and Alternative Medicine, 4 (1):
  • [6] A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease
    Akhondzadeh, Shahin
    Sabet, Mehdi Shafiee
    Harirchian, Mohammad Hossein
    Togha, Mansoreh
    Cheraghmakani, Hamed
    Razeghi, Soodeh
    Hejazi, Seyyed Shamssedin
    Yousefi, Mohammad Hossein
    Alimardani, Roozbeh
    Jamshidi, Amirhossein
    Rezazadeh, Shams-Ali
    Yousefi, Aboulghasem
    Zare, Farhad
    Moradi, Atbin
    Vossoughi, Ardalan
    [J]. PSYCHOPHARMACOLOGY, 2010, 207 (04) : 637 - 643
  • [7] Amin B, 2015, AVICENNA J PHYTOMEDI, V5, P458
  • [8] Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease
    Arabia, Gennarina
    Grossardt, Brandon R.
    Geda, Yonas E.
    Carlin, Justin M.
    Bower, James H.
    Ahlskog, J. Eric
    Maraganore, Demetrius M.
    Rocca, Walter A.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (12) : 1385 - 1392
  • [9] Reversal effects of crocin on amyloid β-induced memory deficit: Modification of autophagy or apoptosis markers
    Asadi, Farideh
    Jamshidi, Amir Hossein
    Khodagholi, Fariba
    Yans, Asal
    Azimi, Leila
    Faizi, Mehrdad
    Vali, Leila
    Abdollahi, Mohammad
    Ghahremani, Mohammad Hossein
    Sharifzadeh, Mohammad
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2015, 139 : 47 - 58
  • [10] Protective properties of the aqueous extract of saffron (Crocus sativus L.) in ischemic stroke, randomized clinical trial
    Asadollahi, Mostafa
    Nikdokht, Parisa
    Hatef, Boshra
    Sadr, Seyed Shahabeddin
    Sahraei, Hedayat
    Assarzadegan, Farhad
    Jahromi, Gila Pirzad
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2019, 238